Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 610 entries
Sorted by: Best Match Show Resources per page
The neurologic consequences of eclampsia.

The neurologist

Kaplan PW.
PMID: 12803666
Neurologist. 2001 Nov;7(6):357-63. doi: 10.1097/00127893-200111000-00005.

BACKGROUND: Toxemia of pregnancy (preeclampsia/eclampsia) is a syndrome characterized by pregnancy-induced hypertension, edema, and proteinuria, although it is often associated with more generalized multisystem abnormalities that affect the nervous system, the liver, kidneys, and coagulation. For the most part,...

Cite
Kaplan PW. The neurologic consequences of eclampsia. Neurologist. 2001;7(6):357-63doi: 10.1097/00127893-200111000-00005.
Kaplan, P. W. (2001). The neurologic consequences of eclampsia. The neurologist, 7(6), 357-63. https://doi.org/10.1097/00127893-200111000-00005
Kaplan, P W. "The neurologic consequences of eclampsia." The neurologist vol. 7,6 (2001): 357-63. doi: https://doi.org/10.1097/00127893-200111000-00005
Kaplan PW. The neurologic consequences of eclampsia. Neurologist. 2001 Nov;7(6):357-63. doi: 10.1097/00127893-200111000-00005. PMID: 12803666.
Copy Download .nbib Format: NLM
Preeclampsia: New Thoughts on an Ancient Problem.

Journal of clinical hypertension (Greenwich, Conn.)

August P.
PMID: 11416634
J Clin Hypertens (Greenwich). 2000 Mar;2(2):115-123.

Preeclampsia is a hypertensive disorder unique to pregnancy and is of unknown cause. It is both a maternal as well as fetal syndrome. It affects 2%-10% of nulliparas, and is more prevalent when preexisting hypertension, renal disease, or diabetes...

Cite
August P. Preeclampsia: New Thoughts on an Ancient Problem. J Clin Hypertens (Greenwich). 2000;2(2):115-123
August, P. (2000). Preeclampsia: New Thoughts on an Ancient Problem. Journal of clinical hypertension (Greenwich, Conn.), 2(2), 115-123.
August, Phyllis. "Preeclampsia: New Thoughts on an Ancient Problem." Journal of clinical hypertension (Greenwich, Conn.) vol. 2,2 (2000): 115-123.
August P. Preeclampsia: New Thoughts on an Ancient Problem. J Clin Hypertens (Greenwich). 2000 Mar;2(2):115-123. PMID: 11416634.
Copy Download .nbib Format: NLM
A theory on bubble-size dependence of the critical electrolyte concentration for inhibition of coalescence.

Journal of colloid and interface science

Chan BS, Tsang YH.
PMID: 15848445
J Colloid Interface Sci. 2005 Jun 01;286(1):410-3. doi: 10.1016/j.jcis.2005.01.048.

The interaction of pairs of bubbles with equal diameters grown on adjacent capillaries in aqueous magnesium sulfate solutions is studied by varying electrolyte concentration and bubble diameter by Tsang, Koh and Koch [Y.H. Tsang, Y.-H. Koh, D.L. Koch, J....

Cite
Chan BS, Tsang YH. A theory on bubble-size dependence of the critical electrolyte concentration for inhibition of coalescence. J Colloid Interface Sci. 2005;286(1):410-3doi: 10.1016/j.jcis.2005.01.048.
Chan, B. S., & Tsang, Y. H. (2005). A theory on bubble-size dependence of the critical electrolyte concentration for inhibition of coalescence. Journal of colloid and interface science, 286(1), 410-3. https://doi.org/10.1016/j.jcis.2005.01.048
Chan, Benjamin S, and Tsang, Ying Hang. "A theory on bubble-size dependence of the critical electrolyte concentration for inhibition of coalescence." Journal of colloid and interface science vol. 286,1 (2005): 410-3. doi: https://doi.org/10.1016/j.jcis.2005.01.048
Chan BS, Tsang YH. A theory on bubble-size dependence of the critical electrolyte concentration for inhibition of coalescence. J Colloid Interface Sci. 2005 Jun 01;286(1):410-3. doi: 10.1016/j.jcis.2005.01.048. PMID: 15848445.
Copy Download .nbib Format: NLM
EFFECT OF SODIUM IODIDE, MAGNESIUM SULFATE, THYROXIN, AND THYROTROPIC HORMONE ON THE BLOOD MAGNESIUM PARTITION.

The Journal of clinical investigation

Soffer LJ, Cohn C, Lesnick G, Sobotka H, Jacobs M.
PMID: 16695100
J Clin Invest. 1944 Mar;23(2):263-6. doi: 10.1172/JCI101489.

No abstract available.

Cite
Soffer LJ, Cohn C, Lesnick G, et al. EFFECT OF SODIUM IODIDE, MAGNESIUM SULFATE, THYROXIN, AND THYROTROPIC HORMONE ON THE BLOOD MAGNESIUM PARTITION. J Clin Invest. 1944;23(2):263-6doi: 10.1172/JCI101489.
Soffer, L. J., Cohn, C., Lesnick, G., Sobotka, H., & Jacobs, M. (1944). EFFECT OF SODIUM IODIDE, MAGNESIUM SULFATE, THYROXIN, AND THYROTROPIC HORMONE ON THE BLOOD MAGNESIUM PARTITION. The Journal of clinical investigation, 23(2), 263-6. https://doi.org/10.1172/JCI101489
Soffer, L J, et al. "EFFECT OF SODIUM IODIDE, MAGNESIUM SULFATE, THYROXIN, AND THYROTROPIC HORMONE ON THE BLOOD MAGNESIUM PARTITION." The Journal of clinical investigation vol. 23,2 (1944): 263-6. doi: https://doi.org/10.1172/JCI101489
Soffer LJ, Cohn C, Lesnick G, Sobotka H, Jacobs M. EFFECT OF SODIUM IODIDE, MAGNESIUM SULFATE, THYROXIN, AND THYROTROPIC HORMONE ON THE BLOOD MAGNESIUM PARTITION. J Clin Invest. 1944 Mar;23(2):263-6. doi: 10.1172/JCI101489. PMID: 16695100; PMCID: PMC435337.
Copy Download .nbib Format: NLM
Best evidence in anesthetic practice: prevention: magnesium sulfate reduces the risk of eclampsia in women with pre-eclampsia.

Canadian journal of anaesthesia = Journal canadien d'anesthesie

Douglas J.
PMID: 14656783
Can J Anaesth. 2003 Dec;50(10):1035-7.

No abstract available.

Cite
Douglas J. Best evidence in anesthetic practice: prevention: magnesium sulfate reduces the risk of eclampsia in women with pre-eclampsia. Can J Anaesth. 2003;50(10):1035-7
Douglas, J. (2003). Best evidence in anesthetic practice: prevention: magnesium sulfate reduces the risk of eclampsia in women with pre-eclampsia. Canadian journal of anaesthesia = Journal canadien d'anesthesie, 50(10), 1035-7.
Douglas, Joanne. "Best evidence in anesthetic practice: prevention: magnesium sulfate reduces the risk of eclampsia in women with pre-eclampsia." Canadian journal of anaesthesia = Journal canadien d'anesthesie vol. 50,10 (2003): 1035-7.
Douglas J. Best evidence in anesthetic practice: prevention: magnesium sulfate reduces the risk of eclampsia in women with pre-eclampsia. Can J Anaesth. 2003 Dec;50(10):1035-7. PMID: 14656783.
Copy Download .nbib Format: NLM
Calcium inhibition of potassium absorption in corn roots.

Plant physiology

Elzam OE, Hodges TK.
PMID: 16656683
Plant Physiol. 1967 Nov;42(11):1483-8. doi: 10.1104/pp.42.11.1483.

Calcium (or magnesium) sulfate or chloride was found to inhibit energy dependent potassium transport in excised corn roots. This Ca(2+) inhibition of K(+) transport was most pronounced during the initial phases of transport. As the absorption periods were lengthened...

Cite
Elzam OE, Hodges TK. Calcium inhibition of potassium absorption in corn roots. Plant Physiol. 1967;42(11):1483-8doi: 10.1104/pp.42.11.1483.
Elzam, O. E., & Hodges, T. K. (1967). Calcium inhibition of potassium absorption in corn roots. Plant physiology, 42(11), 1483-8. https://doi.org/10.1104/pp.42.11.1483
Elzam, O E, and Hodges, T K. "Calcium inhibition of potassium absorption in corn roots." Plant physiology vol. 42,11 (1967): 1483-8. doi: https://doi.org/10.1104/pp.42.11.1483
Elzam OE, Hodges TK. Calcium inhibition of potassium absorption in corn roots. Plant Physiol. 1967 Nov;42(11):1483-8. doi: 10.1104/pp.42.11.1483. PMID: 16656683; PMCID: PMC1086755.
Copy Download .nbib Format: NLM
MAGNESIUM SULFATE VALUELESS AS A CONTROL FOR THE BEAN BEETLE.

Science (New York, N.Y.)

Howard NF.
PMID: 17810556
Science. 1937 Sep 24;86(2230):286-7. doi: 10.1126/science.86.2230.286.

No abstract available.

Cite
Howard NF. MAGNESIUM SULFATE VALUELESS AS A CONTROL FOR THE BEAN BEETLE. Science. 1937;86(2230):286-7doi: 10.1126/science.86.2230.286.
Howard, N. F. (1937). MAGNESIUM SULFATE VALUELESS AS A CONTROL FOR THE BEAN BEETLE. Science (New York, N.Y.), 86(2230), 286-7. https://doi.org/10.1126/science.86.2230.286
Howard, N F. "MAGNESIUM SULFATE VALUELESS AS A CONTROL FOR THE BEAN BEETLE." Science (New York, N.Y.) vol. 86,2230 (1937): 286-7. doi: https://doi.org/10.1126/science.86.2230.286
Howard NF. MAGNESIUM SULFATE VALUELESS AS A CONTROL FOR THE BEAN BEETLE. Science. 1937 Sep 24;86(2230):286-7. doi: 10.1126/science.86.2230.286. PMID: 17810556.
Copy Download .nbib Format: NLM
Minimal nutritional requirements for immobilized yeast.

Biotechnology and bioengineering

Chen C, Dale MC, Okos MR.
PMID: 18595037
Biotechnol Bioeng. 1990 Dec 05;36(10):993-1001. doi: 10.1002/bit.260361004.

The effect of reduced nutritional levels (particularly nitrogen source) for immobilized K. fragilis type yeast were studied using a trickle flow, "differential" plug flow type reactor with cells immobilized by adsorption onto an absorbant packing matrix. Minimizing nutrient levels...

Cite
Chen C, Dale MC, Okos MR. Minimal nutritional requirements for immobilized yeast. Biotechnol Bioeng. 1990;36(10):993-1001doi: 10.1002/bit.260361004.
Chen, C., Dale, M. C., & Okos, M. R. (1990). Minimal nutritional requirements for immobilized yeast. Biotechnology and bioengineering, 36(10), 993-1001. https://doi.org/10.1002/bit.260361004
Chen, C, et al. "Minimal nutritional requirements for immobilized yeast." Biotechnology and bioengineering vol. 36,10 (1990): 993-1001. doi: https://doi.org/10.1002/bit.260361004
Chen C, Dale MC, Okos MR. Minimal nutritional requirements for immobilized yeast. Biotechnol Bioeng. 1990 Dec 05;36(10):993-1001. doi: 10.1002/bit.260361004. PMID: 18595037.
Copy Download .nbib Format: NLM
Efficacy of goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer.

Evidence-based complementary and alternative medicine : eCAM

Kono T, Mamiya N, Chisato N, Ebisawa Y, Yamazaki H, Watari J, Yamamoto Y, Suzuki S, Asama T, Kamiya K.
PMID: 19952054
Evid Based Complement Alternat Med. 2011;2011:418481. doi: 10.1093/ecam/nep200. Epub 2011 Jan 11.

Peripheral neurotoxicity is the major limiting factor for oxaliplatin therapy. Goshajinkigan (GJG), a traditional Japanese herbal medicine, was recently shown to be effective in protecting against the neurotoxicity of taxanes in Japan. We retrospectively investigated the effect of GJG...

Cite
Kono T, Mamiya N, Chisato N, et al. Efficacy of goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer. Evid Based Complement Alternat Med. 2011;2011:418481doi: 10.1093/ecam/nep200.
Kono, T., Mamiya, N., Chisato, N., Ebisawa, Y., Yamazaki, H., Watari, J., Yamamoto, Y., Suzuki, S., Asama, T., & Kamiya, K. (2011). Efficacy of goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer. Evidence-based complementary and alternative medicine : eCAM, 2011418481. https://doi.org/10.1093/ecam/nep200
Kono, Toru, et al. "Efficacy of goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer." Evidence-based complementary and alternative medicine : eCAM vol. 2011 (2011): 418481. doi: https://doi.org/10.1093/ecam/nep200
Kono T, Mamiya N, Chisato N, Ebisawa Y, Yamazaki H, Watari J, Yamamoto Y, Suzuki S, Asama T, Kamiya K. Efficacy of goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer. Evid Based Complement Alternat Med. 2011;2011:418481. doi: 10.1093/ecam/nep200. Epub 2011 Jan 11. PMID: 19952054; PMCID: PMC3135601.
Copy Download .nbib Format: NLM
CRYSTALLINE TRYPSIN : II. GENERAL PROPERTIES.

The Journal of general physiology

Northrop JH, Kunitz M.
PMID: 19872706
J Gen Physiol. 1932 Nov 20;16(2):295-311. doi: 10.1085/jgp.16.2.295.

A method is described for isolating a crystalline protein of high tryptic activity from beef pancreas. The protein has constant proteolytic activity and optical activity under various conditions and no indication of further fractionation could be obtained. The loss...

Cite
Northrop JH, Kunitz M. CRYSTALLINE TRYPSIN : II. GENERAL PROPERTIES. J Gen Physiol. 1932;16(2):295-311doi: 10.1085/jgp.16.2.295.
Northrop, J. H., & Kunitz, M. (1932). CRYSTALLINE TRYPSIN : II. GENERAL PROPERTIES. The Journal of general physiology, 16(2), 295-311. https://doi.org/10.1085/jgp.16.2.295
Northrop, J H, and Kunitz, M. "CRYSTALLINE TRYPSIN : II. GENERAL PROPERTIES." The Journal of general physiology vol. 16,2 (1932): 295-311. doi: https://doi.org/10.1085/jgp.16.2.295
Northrop JH, Kunitz M. CRYSTALLINE TRYPSIN : II. GENERAL PROPERTIES. J Gen Physiol. 1932 Nov 20;16(2):295-311. doi: 10.1085/jgp.16.2.295. PMID: 19872706; PMCID: PMC2141208.
Copy Download .nbib Format: NLM
CRYSTALLINE PEPSIN : V. ISOLATION OF CRYSTALLINE PEPSIN FROM BOVINE GASTRIC JUICE.

The Journal of general physiology

Northrop JH.
PMID: 19872726
J Gen Physiol. 1933 Mar 20;16(4):615-23. doi: 10.1085/jgp.16.4.615.

1. A method has been described for isolating a crystalline protein with high proteolytic activity from bovine gastric juice by means of precipitation with magnesium sulfate and fractionation of the precipitate with acetone and magnesium sulfate. 2. The crystalline...

Cite
Northrop JH. CRYSTALLINE PEPSIN : V. ISOLATION OF CRYSTALLINE PEPSIN FROM BOVINE GASTRIC JUICE. J Gen Physiol. 1933;16(4):615-23doi: 10.1085/jgp.16.4.615.
Northrop, J. H. (1933). CRYSTALLINE PEPSIN : V. ISOLATION OF CRYSTALLINE PEPSIN FROM BOVINE GASTRIC JUICE. The Journal of general physiology, 16(4), 615-23. https://doi.org/10.1085/jgp.16.4.615
Northrop, J H. "CRYSTALLINE PEPSIN : V. ISOLATION OF CRYSTALLINE PEPSIN FROM BOVINE GASTRIC JUICE." The Journal of general physiology vol. 16,4 (1933): 615-23. doi: https://doi.org/10.1085/jgp.16.4.615
Northrop JH. CRYSTALLINE PEPSIN : V. ISOLATION OF CRYSTALLINE PEPSIN FROM BOVINE GASTRIC JUICE. J Gen Physiol. 1933 Mar 20;16(4):615-23. doi: 10.1085/jgp.16.4.615. PMID: 19872726; PMCID: PMC2141232.
Copy Download .nbib Format: NLM
THE USE OF SOLUBILITY AS A CRITERION OF PURITY OF PROTEINS : I. APPLICATION OF THE PHASE RULE TO THE SOLUBILITY OF PROTEINS. II. THE SOLUBILITY CURVES AND PURITY OF CHYMOTRYPSINOGEN.

The Journal of general physiology

Butler JA.
PMID: 19873208
J Gen Physiol. 1940 Nov 20;24(2):189-202. doi: 10.1085/jgp.24.2.189.

1. The conditions under which the phase rule may be applied to systems containing proteins are formulated. 2. An attempt was made to fractionate chymotrypsinogen, by crystallization in stages with increasing concentration of magnesium sulfate. No significant fractionation of...

Cite
Butler JA. THE USE OF SOLUBILITY AS A CRITERION OF PURITY OF PROTEINS : I. APPLICATION OF THE PHASE RULE TO THE SOLUBILITY OF PROTEINS. II. THE SOLUBILITY CURVES AND PURITY OF CHYMOTRYPSINOGEN. J Gen Physiol. 1940;24(2):189-202doi: 10.1085/jgp.24.2.189.
Butler, J. A. (1940). THE USE OF SOLUBILITY AS A CRITERION OF PURITY OF PROTEINS : I. APPLICATION OF THE PHASE RULE TO THE SOLUBILITY OF PROTEINS. II. THE SOLUBILITY CURVES AND PURITY OF CHYMOTRYPSINOGEN. The Journal of general physiology, 24(2), 189-202. https://doi.org/10.1085/jgp.24.2.189
Butler, J A. "THE USE OF SOLUBILITY AS A CRITERION OF PURITY OF PROTEINS : I. APPLICATION OF THE PHASE RULE TO THE SOLUBILITY OF PROTEINS. II. THE SOLUBILITY CURVES AND PURITY OF CHYMOTRYPSINOGEN." The Journal of general physiology vol. 24,2 (1940): 189-202. doi: https://doi.org/10.1085/jgp.24.2.189
Butler JA. THE USE OF SOLUBILITY AS A CRITERION OF PURITY OF PROTEINS : I. APPLICATION OF THE PHASE RULE TO THE SOLUBILITY OF PROTEINS. II. THE SOLUBILITY CURVES AND PURITY OF CHYMOTRYPSINOGEN. J Gen Physiol. 1940 Nov 20;24(2):189-202. doi: 10.1085/jgp.24.2.189. PMID: 19873208; PMCID: PMC2142020.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 610 entries